Skip to content
    Columbus Venture Partners logo

    Columbus Venture Partners

    Valencia, SpainFounded 2016
    columbusvp.com/enLinkedIn
    Biotech & Life SciencesHealthcare

    Columbus Venture Partners is a Spanish venture capital firm specializing in biotechnology and life sciences, investing in therapeutic and industrial biotech platforms. Founded in 2016 in Valencia, it combines therapeutic seed funding with infrastructure creation across Europe and the U.S.

    39% of their portfolio is in Biotech & Life Sciences. Deal activity decreased year-over-year (3 deals in the last 12 months vs 7 prior). Average disclosed round size is $38.3M (across 12 rounds with reported amounts).

    Find people at Columbus Venture Partners on Goldilocks AI

    Portfolio

    26

    Fund Size

    —

    Top Stage

    Seed

    Last 12 Mo

    3

    Team

    DT

    Damia Tormo

    General Partner

    JG

    Javier García

    General Partner

    GR

    Guillermo R.

    Operational Partner

    JF

    Javier Fernández

    Operating Partner

    JM

    Jose Mesa

    Partner

    MV

    Marcos Vasquez

    Investment Analyst

    RF

    Reese Fields

    Venture Capital

    Portfolio Breakdown

    Stage Distribution

    Sector Distribution

    Investment Activity

    DealsAvg Round Size

    Portfolio

    31 investments
    CompanyRoundAmountDate
    Accipiter Biosciences logoAccipiter BiosciencesSeed$12.7MNov 2025
    Accipiter logoAccipiterSeed$12.7MNov 2025
    Arthex Biotech logoArthex BiotechSeries B$87MSep 2025
    DeePuLL logoDeePuLLSeries C—Apr 2025
    DDEEPULL DIAGNOSTICS, S.L.Series C—Apr 2025
    LLutris PharmaUnknown$30MJan 2025
    Accipiter logoAccipiterSeed—Jan 2025
    Tolerance Bio logoTolerance BioSeed$20.2MDec 2024
    Tolerance Bio logoTolerance BioSeed$17.2MOct 2024
    Tolerance logoToleranceSeed$17.2MOct 2024
    Artax Biopharma logoArtax BiopharmaUnknown$8MAug 2024
    SSyngoi TechnologiesSeries B—Jun 2024
    Multiverse Computing logoMultiverse ComputingSeries A—Mar 2024
    Curve Therapeutics logoCurve TherapeuticsSeries A$51.4MFeb 2024
    Fingercheck logoFingercheckGrowth$115MJan 2024
    CCocoon BioscienceGrowth—Mar 2023
    IIntegra TherapeuticsSeed—Mar 2022
    NeRRe Therapeutics logoNeRRe TherapeuticsUnknown—Jul 2021
    Algenex logoAlgenexSeries C—Sep 2020
    Sanifit logoSanifitSeries D—Jun 2019
    MMinoryx TherapeuticsSeries B—Sep 2018
    Vivet logoVivetSeries A—May 2017
    VVivet TherapeuticsSeries A—May 2017
    NeRRe Therapeutics logoNeRRe TherapeuticsSeries B—Jan 2017
    VVivet TherapeuticsSeries A—Jan 2017
    Page 1 of 2

    Top Co-Investors

    Ysios Capital7 shared
    Kurma Partners7 shared
    Caixa Capital Risc6 shared
    Roche Venture Fund5 shared
    Argonautic Ventures3 shared
    HealthCap3 shared
    Forbion3 shared
    Asabys Partners3 shared
    Ben Franklin Technology Partners3 shared
    AdBio partners2 shared
    Bpifrance2 shared
    European Innovation Council (EIC)2 shared
    WRF Capital2 shared
    Flying Fish2 shared
    Alexandria Venture Investments2 shared
    Cercano Management2 shared
    Takeda Ventures, Inc.2 shared
    Fund+2 shared
    Idinvest Partners2 shared
    We Venture Capital2 shared

    Last updated: 8 September 2026